Cambrex Corp., which provides drug substance, drug product and analytical services across the drug lifecycle, has completed construction on a $24 million highly potent API manufacturing facility in Charles City, Cambrex reports. The 6,000 square-feet facility is undergoing validation and will be ready to launch projects in May.
